HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.

AbstractOBJECTIVE:
Although body dysmorphic disorder often responds to serotonin reuptake inhibitors (SRIs), most patients do not respond or respond only partially. However, placebo-controlled studies of augmentation of SRIs have not been done. Furthermore, although 40%-50% of patients are delusional, studies of antipsychotic medications have not been done.
METHOD:
Twenty-eight patients with body dysmorphic disorder or its delusional variant participated in an 8-week, placebo-controlled, double-blind, parallel-group study of pimozide augmentation of fluoxetine.
RESULTS:
Pimozide was not more effective than placebo: two (18.2%) of 11 subjects responded to pimozide and three (17.6%) of 17 subjects responded to placebo. There was no significant effect of baseline delusionality on endpoint severity of body dysmorphic disorder. Delusionality did not decrease significantly more with pimozide than placebo.
CONCLUSIONS:
Pimozide augmentation of fluoxetine treatment for body dysmorphic disorder was not more effective than placebo, even in more delusional patients. Further studies of augmentation for SRIs are needed.
AuthorsKatharine A Phillips
JournalThe American journal of psychiatry (Am J Psychiatry) Vol. 162 Issue 2 Pg. 377-9 (Feb 2005) ISSN: 0002-953X [Print] United States
PMID15677604 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
  • Placebos
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Pimozide
Topics
  • Adult
  • Antipsychotic Agents (therapeutic use)
  • Delusions (drug therapy, psychology)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Fluoxetine (therapeutic use)
  • Humans
  • Male
  • Pimozide (therapeutic use)
  • Placebos
  • Psychiatric Status Rating Scales
  • Selective Serotonin Reuptake Inhibitors (therapeutic use)
  • Somatoform Disorders (diagnosis, drug therapy, psychology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: